Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
67 Cards in this Set
- Front
- Back
|
WHAT TYPES OF MER'S DO WE HAVE?
|
(1) Suspected
(2) Probable (3) Confirmed |
|
|
INH DOSAGE AND INTERVALS
|
300MG (5MG/KG) ONCE A DAY FOR 9 MONTHS
900MG (15MG/KG) TWICE A WEEK FOR 9 MONTHS |
|
|
REQUIREMENTS FOR RECONSTITUTING VACCINES
|
Multidose vial of reconstituted vaccine must be discarded after 1 hour of reconstitution
|
|
|
ELEMENTS OF TB CONTROL PROGRAM
|
(1) Tuberculosis Screening and Testing
(2) Evaluation and Management of New Positive Test for Latent Tuberculosis Infection |
|
|
REQUIREMENTS FOR CHEST X-RAYS
|
ENTRY INTO NAVAL SERVICE
SEPARATION FROM NAVAL SERVICE NEW TB REACTOR, ANYTIME ACTIVE DISEASE IS SUSPECTED, New and previous reactors who are contacts of potentially infectious case of active disease |
|
|
ROUTE AND ADMINISTRATION OF MMR
|
Dosage: 0.5ml.
Route - subcutaneous. Periodicity - single dose one time only. Exception: |
|
|
BCG VACCINES
|
STILL GIVE TB TEST, THEY WILL BE POSITIVE FOR LATENT TB
|
|
|
24 HOUR REPORTABLE DISEASE
|
(1) Amebiasis.
(2) Anthrax. (3) Biological Warfare Agent Exposure. (4) Botulism. (5) Cholera.. (6) Dengue fever (7) E. coli 0157:H7 infection. (8) Encephalitis (arboviral and tick-borne). (9) Hantavirus infection (10) Hemorrhagic fever (specify type). (11) Legionellosis. (12) Malaria (all). (13) Measles. (14) Meningococcal disease. (15) Pertussis. (16) Plague. (17) Q Fever (18) Rabies, clinical human. (19) Smallpox. (20) Tuberculosis, pulmonary . (21) Tularemia. (22) Typhoid fever. (23) Typhus Fever. (24) Yellow fever. (25) Outbreaks |
|
|
TB DOSAGE NUMBERS AND UNITS
|
.1ML, 5 TUBERCULIN UNITS
80 IN A VIAL |
|
|
SMALLPOX IMPORTANT DATES
|
OCTOBER 1977 LAST KNOWN CASE, 1979 GLOBAL ERADICATION
|
|
|
MMR STORAGE TEMPS
|
Store between -58 ºF to 46 ºF
|
|
|
PPD RESULTS- HIGH RISK: REACTION >5 mm OF INDURATION IS CONSIDERED POSITIVE IN:
|
RECENT CLOSE CONTACTS OF ACTIVE TB DISEASE PATIENTS
PERSONS WITH FIBROTIC OR OTHER CHANGES ON CHEST RADIOGRAPH CONSISTENT WITH PRIOR TB PATIENT SUSPECTED OF HAVING TB DISEASE |
|
|
PPD RESULTS- MEDIUM RISK:
> 10mm OF INDURATION CONSIDERED POSITIVE IN: |
RECENT IMMIGRANTS WITHIN THE LAST 5 YEARS, FROM HIGH TB PREVALENCE COUNTRIES
MYCOBACTERIOLOGY LABORATORY PERSONNEL PERSONS WITH CLINICAL CONDITIONS THAT PLACE THEM AT INCREASES RISK |
|
|
PPD RESULTS- LOW RISK:
REACTION > 15MM OF INDURATION IS CONSIDERED POSITIVE IN: |
PERSONS WITH NO RISK FACTORS FOR TB
|
|
|
SYMPTOMS OF TB
|
weakness, weight loss, fatigue, fever, loss of appetite, chills
and night sweats. 2)Other symptoms of TB disease depend on the location of infection in the body. a) If in the lungs (pulmonary TB), the symptoms may include a bad cough, chest pain, dyspnea, hoarseness, and hemoptysis. |
|
|
WHAT TO DO WITH PERSONS WITH TB SYMPTOMS?
|
(a) Reporting requirements to health agencies.
(b)Contact investigation and management. (c) Isolation and specific treatment protocols. (d)Periodic liver function tests (LFTs) to monitor hepatotoxicity |
|
|
PURPOSE OF THE MER
|
a. Enables Navy public health experts to be aware of:
(1) Important medical events when they occur (2) Prevention and control actions already taken by or being considered by local level medical staff b. Enables Navy public health experts to be proactive in offering their assistance to local level medical staff. |
|
|
WHAT DOES THE WHO DO?
|
WHERE ALL WORLD WIDE AGENCIES REPORT REPORTABLE DISEASES AND OUTBREAKS
|
|
|
WHEN IS TB TEST REQUIRED
|
ENTRY INTO SERVICE
All individual beginning employment as CIVMAR for the MSC Periodic screening (LTBI Screening) |
|
|
QUARANTINABLE DISEASE IRT WORLD WIDE TRAVEL
|
CHOLERA
(2) Diphtheria (3) Infectious Tuberculosis (4) Plague (5) Smallpox (6) Yellow Fever (7) Viral Hemoragic Fevers (8) SARS (9) Influenza caused by novel or reemergent influenza viruses that are causing, or have the potential to cause, a pandemic |
|
|
HOW DO YOU CONTROL SOME QUARANTINABLE DISEASES
|
(1) Active immunization with oral vaccines provide high levels of protection for several
months. (2) Case report universally required by World Health Organization (WHO), Medical Event Report (MER). (3) Isolation with enteric precautions of severely-ill patients, hand-washing and fly control. (4) Concurrent disinfection of feces and vomitus of linens and articles used by patients |
|
|
SUDDEN INCREASE OF INFECTIOUS COMMUNICABLE DISEASES
|
OUTBREAK
|
|
|
WHAT IS A GOOD INDICATOR OF A TB CASE INFECTIVITY
|
SIGNIFICANT NEW REACTOR RATE
|
|
|
HOW DO YOU CONTRACT CHOLERA?
|
BY DRINKING WATER OR EATING FOOD CONTAMINATED WITH CHOLERA BACTERIUM
|
|
|
HOW DO WE ADMINISTER PPD TEST
|
MANTOUX METHOD, VOLAR ASPECT OF ARM
|
|
|
WHAT ARE THE REGULATIONS FOR QUARANTINABLE CONDITIONS AS IT RELATES TO FOREIGN PORTS?
|
2) Quarantine regulations are intended to prevent the introduction and dissemination,
domestically or internationally originated, of diseases affecting: (a) humans, plants, and animals; (b)prohibited or illegally taken wildlife; (c)arthropod vectors; (d)and pests of health and agricultural importance |
|
|
WHAT ARE OTHER WAYS TO TEST FOR TB
|
SKIN & BLOOD TEST
|
|
|
WHAT TO DO WHEN PERSONS ARE NOT TB MEDICATION COMPLIANT?
|
DIRECTLY OBSERVED THERAPY
|
|
|
NDRSI
|
NAVY DISEASE REPORTING SYSTEM INTERNET
|
|
|
HOW OFTEN ARE THE 2009 REPORTABLE DISEASES
|
24 HOURS AND MONTHLY
|
|
|
ANTHRAX DOSAGE
|
0.5 ML, INTRAMUSCULAR
|
|
|
HEP B INTERVAL AND DOSAGE
|
0, 1 MONTH, 6 MONTHS
1.0CC INTRAMUSCULAR |
|
|
JEV DOSAGE AND INTERVAL
|
1.0 ML, SUBCUTAENOUS
DAYS 0,7 AND 30 |
|
|
YELLOW FEVER DOSAGE
|
0.5 ML, SUBCUTAENOUS, EVERY 10 YEARS
|
|
|
DOSAGE FOR CHOLERA
|
0.5ML SUBCUTAENOUS, EVERY 6 MONTHS
|
|
|
VACCINE INFORMATION SHEETS
|
(3) Providers will use only vaccine information sheets prepared by the Department of
Health and Human Services, Centers for Disease Control and Prevention |
|
|
CONTRAINDICATIONS FOR PREGNANT WOMAN
|
(2) Live virus vaccines should not be routinely administered to any pregnant female.
(a) Can be given if ordered by attending physician for specific prevention or for international travel. (b) Polio and yellow fever vaccine may be administered if risks of contracting illness outweigh potential complications. |
|
|
IMMUNIZATION SUPPORT TO SHIPS
|
(2) All immunizations, except yellow fever, may be given at sea or ashore at the discretion
of the MDR with the concurrence of the Commanding Officer. (3) Yellow fever immunizations on IDC ships shall only be conducted in port during normal working hours after prior notification and concurrence of local ISIC/RSG/Group M.O., unless a Medical Officer is present. |
|
|
IMMUNIZATIONS RECORDS
|
a) NAVMED 6230/4 (rev. 1-2004)
(b) PHS 731 (International Certificate of Vaccination) (c) Electronic database |
|
|
VACCINE INSTRUCTION
|
BUMEDINST 6230.15A
|
|
|
IMMUNIZATION WAIVERS/ MEDICAL EXEMPTIONS
|
(1) Includes any medical contraindication relevant to specific vaccine
(2) May be temporary (up to 365 days) or Permanent (3) General examples are: (a) Underlying health condition of the vaccine candidate (b) Evidence of immunity based on: b. Administrative Exemptions (1) Separation or retirement (2) Religious |
|
|
REPORTING REQUIREMENTS FOR IMMUNIZATIONS
|
AHLTA, MRRS OR SAMS
|
|
|
OPNAVINST 6210.2
|
Provides guidance on Navy’s responsibilities, liaisons, foreign quarantine and Public
Health Service requirements |
|
|
BUMEDNOTE 6210
|
Identifies Navy medical personnel delegated authority in accordance with
OPNAVINST 6210.2 and the World Health Organization, International Health Regulations (IHRs) to inspect and issue appropriate Ship Sanitation Certificates (SSC) and to provide related standard procedures and policy for the Ship Sanitation Certificate Program (SSCP). |
|
|
OPNAVINST 6210.2
|
(Quarantine Regulations of the Navy)
|
|
|
BUMEDNOTE 6210
|
Shipboard Sanitation Certificate Program
|
|
|
NAVMED P-5010, CHAPTER 8
|
NAVY ENTOMOLOGY AND PEST CONTROL TECHNOLOGY
|
|
|
BUMEDINST 6224.8A, 12 Feb 2009)
|
Tuberculosis Control Program,
REQUIREMENTS FOR INH THERAPY |
|
|
Medical Services Immunizations and Chemoprophylaxis,
|
BUMEDINST 6230.15 series
|
|
|
CHOLERA METHODS OF CONTROL
|
(1) Active immunization with oral vaccines provide high levels of protection for several
months. (2) Case report universally required by World Health Organization (WHO), Medical Event Report (MER). (3) Isolation with enteric precautions of severely-ill patients, hand-washing and fly control. (4) Concurrent disinfection of feces and vomitus of linens and articles used by patients. |
|
|
U.S. PORT QUARANTINE REQUIREMENTS
|
LAST 15 DAYS PRIOR TO ARRIVAL IN THE U.S.
TEMP 100 DEG F OR 38 DEG C DIARRHEA 3 OR MORE TIMES IN 24HR PERIOD |
|
|
WHEN WILL C.O. NOTIFY REPORTING AUTHORITY
|
24-72 HOURS PRIOR TO ENTERING PORT BY MESSAGE OR RADIO
|
|
|
TB TEST SYRINGE
|
25 GAUGE 5/8INCH NEEDLE
|
|
|
Mycobacterium tuberculosis
|
Bacteria that cause latent TB infection and active TB disease.
|
|
|
ACTIVE TB DISEASE
|
An illness in which TB bacteria are multiplying and attacking a part of the body,
usually the lungs.. |
|
|
LATENT TB INFECTION
|
(a) A condition in which TB bacteria are alive but inactive in the body.
(b) People with latent TB infection have no symptoms, don't feel sick, can't spread TB to others, and usually have a positive skin test reaction. |
|
|
TB SKIN TEST
|
A test that is often used to find out if you are infected with TB bacteria.
|
|
|
TB BLOOD TEST
|
A new test that uses a blood sample to find out if you are infected with TB bacteria.
|
|
|
BCG
|
(a) A vaccine for TB named after the French scientists who developed it, Calmette and
Guérin. (b)BCG is rarely used in the United States, but it is often given to infants and small children in other countries where TB is common |
|
|
DOT- DIRECTLY OBSERVED THERAPY
|
(a) A way of helping patients take their medicine for TB.
(b)If you get DOT, you will meet with a health care worker every day or several times a week |
|
|
Effective Prevention Therapy
|
(1) The antibiotic regimen of choice for tuberculosis preventive therapy is INH in an oral
daily dose of 5mg/kg (300 mg max) for 9 months to accomplish 270 daily doses within 12 months. (2) An alternate regimen is INH 15mg/kg (900mg max) twice weekly for 9 months. (a) This may be used only in combination with directly observed therapy (DOT). |
|
|
PERIODIC SCREENING (LTBI)
|
ACTIVE DUTY, RESERVE
CIVMAR'S INDIVIDUALS AT RISK FOT TB AS DIRECTED, INVESTIGATION, CLINICALLY INDICATED, COGNIZANT NEPMU SUITABILITY SCREENING 6 MONTHS PRIOT TO SEPARATION OR RETIREMENT |
|
|
SIGNIFICANT NEW REACTOR RATE
|
(1) The percent of close contacts who are TB reactors or converters is a good indicator of a
case's infectivity |
|
|
Bacillus Calmette Guerin (BCG)
|
BCG vaccines made from live-attenuated bacteria are commonly used in certain
countries to avert infection with M. tuberculosis |
|
|
pnuemonic plague
|
(a)Extensive involvement of lungs, sputum loaded with causative agent.
(b)Respiratory droplets may serve as source of propagation, leading to outbreaks or epidemics. |
|
|
bubonic plague
|
(a)Lymphadenitis develops in lymph nodes receiving drainage from the site of the flea
bite, where there may be an initial lesion. (b)Fever is usually present |
|
|
Advisory Committee on Immunization Practices (ACIP)
|
Consists of experts in fields associated with immunization, who have been selected by
the Secretary of the U.S. Department of Health and Human Services to provide advice and guidance to the Secretary, the Assistant Secretary for Health, and the Center for Disease Control and Prevention (CD) on the control of vaccine-preventable diseases. |
